163 related articles for article (PubMed ID: 36585180)
1. Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.
Hashimoto M; Fujita K; Tomiyama E; Fujimoto S; Adomi S; Banno E; Minami T; Takao T; Nozawa M; Fushimi H; Yoshimura K; Nonomura N; Uemura H
Anticancer Res; 2023 Jan; 43(1):167-174. PubMed ID: 36585180
[TBL] [Abstract][Full Text] [Related]
2. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
3. Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma.
Okuda Y; Kato T; Fujita K; Fushimi H; Miyamoto H; Netto GJ; Nonomura N
Cancer Genomics Proteomics; 2024; 21(2):137-143. PubMed ID: 38423597
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis for human epidermal growth factor receptor 2 on upper tract urothelial carcinoma patients.
Ye J; Liao X; Qiu Y; Wei Q; Bao Y
Tumori; 2024 Feb; 110(1):25-33. PubMed ID: 37555322
[TBL] [Abstract][Full Text] [Related]
5. HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).
Soria F; Moschini M; Haitel A; Wirth GJ; Karam JA; Wood CG; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Raman JD; Kammerer-Jacquet SF; Mathieu R; Bensalah K; Lotan Y; Özsoy M; Remzi M; Gust KM; Shariat SF
World J Urol; 2017 Feb; 35(2):251-259. PubMed ID: 27272502
[TBL] [Abstract][Full Text] [Related]
6. [Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance].
Erben P; Wezel F; Wirtz R; Martini T; Stein D; Weis CA; Hartmann A; Bolenz C
Aktuelle Urol; 2017 Aug; 48(4):356-362. PubMed ID: 28750448
[No Abstract] [Full Text] [Related]
7. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
Yates DR; Catto JW
World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
[TBL] [Abstract][Full Text] [Related]
8. Genomic Characterization of Upper Tract Urothelial Carcinoma.
Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
[TBL] [Abstract][Full Text] [Related]
9. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
van Doeveren T; Nakauma-Gonzalez JA; Mason AS; van Leenders GJLH; Zuiverloon TCM; Zwarthoff EC; Meijssen IC; van der Made AC; van der Heijden AG; Hendricksen K; van Rhijn BWG; Voskuilen CS; van Riet J; Dinjens WNM; Dubbink HJ; van de Werken HJG; Boormans JL
Int J Cancer; 2021 Feb; 148(4):981-987. PubMed ID: 33006377
[TBL] [Abstract][Full Text] [Related]
10. Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
Li K; Wang F; Wang J; Fan C; Sun J
J Cancer Res Ther; 2021 Dec; 17(7):1709-1717. PubMed ID: 35381743
[TBL] [Abstract][Full Text] [Related]
11. Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
Tomiyama E; Fujita K; Rodriguez Pena MDC; Taheri D; Banno E; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Yamaguchi S; Fushimi H; Yoshimura K; Uemura H; Netto GJ; Nonomura N
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751328
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma.
Li J; Jackson CL; Yang D; Noble L; Wheeler M; MacKenzie D; Adegun T; Amin A
Target Oncol; 2015 Sep; 10(3):355-63. PubMed ID: 25293577
[TBL] [Abstract][Full Text] [Related]
13. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
14. Significance of p53, p27, Ki-67, E-cadherin, and HER2 expression in upper urinary tract urothelial carcinoma.
Missaoui N; Bdioui A; Baccouche A; Belkacem O; Hmida W; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2020 Sep; 32(1):36. PubMed ID: 32929553
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of molecular signatures in the urinary bladder and upper tract urothelial carcinomas: a prospective controlled clinical study.
Dawood EE; Awadalla A; Hashem A; Shokeir AA; Abdel-Aziz AF
J Egypt Natl Canc Inst; 2022 Nov; 34(1):47. PubMed ID: 36372809
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
Wirth GJ; Haitel A; Moschini M; Soria F; Klatte T; Hassler MR; Bensalah K; Briganti A; Karam JA; Lotan Y; Margulis V; Raman JD; Remzi M; Rioux-Leclercq N; Robinson BD; Rouprêt M; Wood CG; Shariat SF
World J Urol; 2017 Jun; 35(6):943-949. PubMed ID: 27730305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
